FDA Approves Unknown Drug — MICRO LABS
# FDA Approves New Generic Drug Application for Micro Labs Micro Labs received FDA approval for ANDA220104 on May 19, 2026, expanding its generic pharmaceutical portfolio and posi…
SEC 8-K filings, insider trades, FDA approvals, Federal Reserve statements, and market-moving events — AI-curated, updated every 60 seconds.
# FDA Approves New Generic Drug Application for Micro Labs Micro Labs received FDA approval for ANDA220104 on May 19, 2026, expanding its generic pharmaceutical portfolio and posi…
Maui Land & Pineapple Co. Inc. signed a memorandum of understanding with the County of Maui to transfer its West Maui water infrastructure, including the Honokohau Ditch System, Pu…
BUZZ HPC acquired 25 acres of land for $58 million and announced a planned 320 MW AI gigafactory in the GTA with expected online date in H2 2027 and CAD $3.5 billion capital invest…
CEO Darin Myman detailed the company's shift toward privacy-first localized agentic AI and progress on social platforms DatChat and Picture Party, which launched in January 2026. T…
Bridgeline reported flat quarterly revenue of $3.9 million but achieved record new customer wins with $875K in ARR added and core ARR per customer doubling to $44K year-over-year. …
News Corporation filed a daily buy-back notification with the ASX on May 19, 2026, disclosing an "Other buy-back" repurchase program authorized for up to US$1 billion of the compan…
Entrada shared a corporate presentation on its ENTR-601-44 candidate in Duchenne muscular dystrophy, outlining expectations for open-label period completion by end-2026 and multipl…
FG Nexus announced a $0.50 per share quarterly cash dividend on its 8.00% Cumulative Preferred Stock, Series A, payable June 15, 2026 to shareholders of record June 1, 2026. The co…
Granite Construction priced a $600 million offering of 6.375% senior notes due 2034, with closing expected June 2, 2026. Proceeds will redeem $827.3 million of convertible notes du…
Sonida Senior Living has entered into an equity distribution agreement allowing it to sell up to $250 million of common stock through an at-the-market program with major financial …
Cullinan Therapeutics announced initial clinical data from two Phase 1 studies of CLN-978, a CD19xCD3 T cell engager, showing favorable safety profile and robust B cell depletion w…
Commercial Vehicle Group filed a second amended and restated 2020 equity incentive plan to provide stock-based compensation to directors, officers and employees. The plan amendment…
Rocky Brands' board declared a quarterly cash dividend of $0.17 per share payable June 15, 2026 to shareholders of record as of June 1, 2026. The announcement demonstrates ongoing …
# FDA Approves QUAGEN's ANDA Application, Expanding Generic Drug Portfolio QUAGEN has received FDA approval for ANDA216910, strengthening its position in the generic pharmaceutica…
Jerome H. Powell has been named chair pro tempore of the Federal Reserve Board. He will serve in this interim capacity until Kevin M. Warsh is sworn in as the new permanent chair.
The Federal Reserve Board has approved an application submitted by the Stephen M. Calk 2025 Trust. The specific details and implications of the approval were not disclosed in the a…
The Federal Reserve Board does not object to United Texas Bank of Dallas converting from a Federal Reserve-supervised bank to a national bank supervised by the Office of the Comptr…
The Federal Reserve Board has terminated all enforcement actions against UBS Group AG, Credit Suisse AG, and related entities. This action follows UBS's acquisition of Credit Suiss…
# FDA Approves Accord BioPharma Biologic; Entry Expected to Intensify Market Competition Accord BioPharma Inc. has received FDA approval for a new biologic therapeutic under BLA76…
# FDA Approves Jubilant Generics ANDA Application Jubilant Generics received FDA approval for ANDA210329 on May 15, 2026, positioning the company to capture market share in the ge…